About Angelman Syndrome
About FAST
For Researchers
Welcome
Apply for a Grant
Grant Application Process
FAST-Funded Research
For Pharma
Welcome
The Pharma-Research-Community Hub
FAST Ventures
Resources
For Families & Caregivers
Welcome
Newly Diagnosed?
Understanding AS Genetics and Genotypes
Treatment & Trials
Get Involved
Resources for Caregivers
For Donors & Investors
Welcome
Cure Angelman Now (CAN)
FAST Ventures
Contact Us
Menu
Welcome to the Foundation for Angelman Syndrome Therapeutics
We have one goal: to cure Angelman syndrome.
For Researchers
For Pharma
For Families & Caregivers
For Donors & Investors
Not sure where to go? Start here.
Angelman Syndrome News
12/08/2023
Advocacy: FAST & ASF work together for policy change
11/28/2023
Good Morning, Gus
11/28/2023
CAN Spotlight: Hole Out Fore Heath
11/22/2023
FAST announces new board chair, Ryan Jacob
11/22/2023
Ryan Jacob Assumes Board Chair Role At Foundation for Angelman Syndrome Therapeutics
11/21/2023
2023 Cure Angelman Now (CAN) Fundraising Recap
11/20/2023
UNC Brain Development Study of Infants with AS
11/20/2023
CAN Spotlight: Remi Cup
10/16/2023
Ultragenyx Pharmaceutical provides AS Development Pipeline Updates
10/13/2023
Recruitment Open for Roche Aldebaran Study
10/10/2023
New FAST-funded Study on Brain-Derived Neurotrophic Factor Activity
10/03/2023
NIH Announces Large Grant for Gene Editing Platform to Yale University, Foundation for Angelman Syndrom...
10/03/2023
New FAST and ABOM Study Focuses on Motor Function as a Critical Aspect of Angelman Syndrome
09/05/2023
New publication supported by FAST and ABOM about the Vineland Adaptive Behavior Scales
08/28/2023
Welcome, FAST Poland
12/08/2023
Advocacy: FAST & ASF work together for policy change
11/28/2023
Good Morning, Gus
11/28/2023
CAN Spotlight: Hole Out Fore Heath
11/22/2023
FAST announces new board chair, Ryan Jacob
11/22/2023
Ryan Jacob Assumes Board Chair Role At Foundation for Angelman Syndrome Therapeutics
11/21/2023
2023 Cure Angelman Now (CAN) Fundraising Recap
11/20/2023
UNC Brain Development Study of Infants with AS
11/20/2023
CAN Spotlight: Remi Cup
10/16/2023
Ultragenyx Pharmaceutical provides AS Development Pipeline Updates
10/13/2023
Recruitment Open for Roche Aldebaran Study
10/10/2023
New FAST-funded Study on Brain-Derived Neurotrophic Factor Activity
10/03/2023
NIH Announces Large Grant for Gene Editing Platform to Yale University, Foundation for Angelman Syndrom...
10/03/2023
New FAST and ABOM Study Focuses on Motor Function as a Critical Aspect of Angelman Syndrome
09/05/2023
New publication supported by FAST and ABOM about the Vineland Adaptive Behavior Scales
08/28/2023
Welcome, FAST Poland
